Tunnel exchange mutagenesis
For the tunnel mutagenesis, the initial inspection was performed in TmCHMO, where all residues that contribute with their side chain to the tunnel were identified. Subsequently, a structural alignment with phenylacetone monooxygenase (PAMO) was performed, and the conservation of these tunnelcontributing residues was investigated. In Tables S3-S5 , all the residues of PAMO and TmCHMO forming the tunnel and the active site are listed and aligned. As there were differences, rational decisions had to be made. One side wall, which in TmCHMO is formed by T245, V246, E252, F279 and F283 (corresponding to P253, G254, Q260, P286 and A290 in PAMO), instead is created by only one big residue in PAMO: R258 (homologous to F250 in TmCHMO, where it is no tunnel residue, but in the row behind and more outwards exposed). Therefore, it was decided to include P253, G254, Q260, P286 and A290 in the "TmCHMO-to-PAMO" tunnel transplantation experiment. A further difference, in this region was that PAMO has two glycine deletions when compared to TmCHMO. These are usually but incorrectly aligned as a double deletion after PAMO position G285. However, the structural alignment reveals it to be two distinct deletions: one after G285 and the other after A290. Therefore, the proper mutations seem to be P286GF and A290FG to fully reconstitute the TmCHMO situation. Two more glycine insertion/deletions (indels) were found when comparing the entire structure of PAMO and TmCHMO: PAMO's G330 and G334, which are insertions in PAMO and deletions in TmCHMO. G330 is far away from the tunnel and thus was not mutated; however, G334 and the adjacent F333 of PAMO are close, and G334 actively shapes the tunnel in PAMO, and it was therefore mutated.
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Materials and Methods
General
All chemical reagents were purchased from Sigma-Aldrich or TCI Europe, unless otherwise stated. Oligonucleotide primers were synthetized by Sigma-Aldrich or Eurofins. DNA sequencing was performed by GATC (Konstanz, Germany) and Eurofins Genomics (Ebersberg, Germany). Codonoptimized, synthetic genes were ordered from GenScript (New Jersey, USA).
Protein crystallization, X-Ray data collection, and structure determination Native TmCHMO was co-crystallised with hexanoic acid at 293 K using the sitting-drop vapour diffusion technique at 20 °C. Equal volumes of 12 mg mL -1 TmCHMO in 20 mM Tris/HCl containing 5 mM hexanoic acid at pH 7.5 and reservoir solution were mixed. The reservoir solution contained 25% PEG 6000 in 0.1 M Tris/HCl at pH 8.5 (w/v). Crystals were cryoprotected by soaking in the reservoir solution containing 20% glycerol (v/v). X-Ray diffraction data were collected at the PXIII beamline of the Swiss Light Source in Villigen, Switzerland (SLS) and at the BM14-1 beamline of the European Synchrotron Radiation Facility in Grenoble, France (ESRF). The images were integrated and scaled using MOSFLM 1 . Intensities were merged and converted to amplitudes with Aimless 2 and other software of the CCP4 Suite 3 (Table S1 ). The structures were solved with MOLREP 4 , and the coordinates of TmCHMO (PDB code 5M10) as search model 5 . COOT 6 and REFMAC5 7 were employed to carry out alternating cycles of model building and refinement.
Computational methods
All structures were based on the structure of TmCHMO in the oxidized state as deposited in the PDB with the PDB code 5M10 5 . Before modeling, the structure was cleaned: alternative side-chain rotamers with higher B-factor were eliminated, hydrogens were added and optimally oriented, and water, buffer and the ligand were removed. The force field for all simulations was Amber14. The figures in the manuscript were created using YASARA 
Mutant model
The model of the mutant structure shown in Figure 2 was prepared using YASARA, by employing a script that swaps the respective amino acids, and subsequently performs a dead end elimination optimization based on rotamers, making use of the SCWRL3 algorithm 9 and further optimizes the orientation considering force field and solvation energies 10 . The resulting structure is then energy minimized. This approach is repeated in six rounds, with increasing volume of flexible atoms around the mutated site until finally the entire protein is energy minimized.
Flavin intermediate models
The peroxyflavin in Figure 1b was manually modeled by first adding a hydrogen to the flavin N5 atom, then adding the peroxygroup to the re-side of the flavin at the C4a atom, while updating the bond orders. The entire structure except the peroxygroup, the C4a, and the C4a bonding atoms was frozen and an energy minimization yielded the out-of-plane C4a, with the distal negatively charged oxygen. The Criegee-intermediate in Figure 1c was created by superimposing the model of the peroxyflavin with the original structure with hexanoic acid bound in the active site. The distal oxygen of the peroxygroup was deleted, and a single bond was added between the remaining oxygen of the peroxygroup and the oxygen of hexanoic acid that was closest. Next, an energy minimization was performed on the entire complex in a simulation box that extended 5 Å around the protein and which was filled with water molecules and neutralized using Na + and Cl -ions.
Molecular biology methods
QuikChange mutagenesis
A modified QuikChange protocol 11 was used to introduce single mutations. PCRs were conducted in thinwalled PCR tubes (Bio-Rad) using the Pfu Ultra II Hotstart MasterMix (Agilent). As template served the codon-optimized, synthetic gene of TmCHMO cloned in a pBAD-SUMO vector, where the gene is Nterminally fused to the SUMO (small ubiquitin-related modifier) protein for improved expression 12 and a 6x-His tag for affinity chromatography. The PCR program was 95 °C -3 min; (95 °C -30 s; 55 °C -30 s; 72 °C -3 min) x 26; 72 °C -12 min. 10 U DpnI were then added to digest the template plasmid. After at least 4 h reaction, 3.5 µL were transformed in chemically competent E. coli NEB10beta cells via a 30 s heatshock at 42 °C. A single colony was grown to extract the mutated plasmid using the QIAprep Spin miniprep kit (QIAGEN), which was sent for sequencing at Eurofins Genomics.
Multichange isothermal mutagenesis (MISO)
To generate a multiple mutant in one step, a protocol based on PCR and Gibson assembly was used 13 . For each mutation, an approximately 40 bp long, completely overlapping pair of primers that contained the mutated bases were designed. Next, PCR was performed combining the forward primer of one mutation with the reverse primer of the next mutation. The PCR products were gel purified (QIAquick gel extraction kit, QIAGEN), and assembled with Gibson cloning using a self-made reaction mix 14 . After transformation in E. coli NEB10beta, plasmids were isolated from single colonies and sent for sequencing.
Biochemical methods Protein expression and purification
All proteins were produced in E. coli NEB10beta transformed with the pBAD-SUMO-TmCHMO (wild type or mutated) construct. A 5 mL culture tube with Luria-Bertani (LB) medium and ampicillin (50 μg/mL) was inoculated from a glycerol stock. After overnight growth (37 °C, 135 rpm), it was used to inoculate a main culture of TB medium with ampicillin. Induction of the PBAD promoter controlled gene occurred together with inoculation by supplementing the medium with 0.02% L-arabinose. The culture was grown in an Erlenmeyer flask with sufficient head space at 24 °C for 36 h. Cells were harvested by centrifugation (6,000 × g for 15 min at 4 °C, JA-10.5 rotor, Beckman Coulter), re-suspended in Tris/HCl pH 7.5 buffer, and lysed via sonication. The cell debris was removed by centrifugation (15,000 × g for 45 min at 4 °C, JA-17 rotor, Beckman Coulter) and the clear cell extract applied to a gravity flow column containing buffer equilibrated Ni 2+ -Sepharose (GEHealthcare). The flow-through was discarded and the column washed first with Tris/HCl pH 7.5 and then with Tris/HCl pH 7.5 containing 5 mM imidazole. Next, the protein was eluted using Tris/HCl pH 7.5 containing 500 mM imidazole. The eluate was then subjected to an Econo-Pac 10DG desalting column (Bio-Rad), and the resulting purified protein was shock frozen in liquid N2.
Bioconversions with purified enzyme
The conversion solutions typically contained 50 mM Tris/HCl pH 7.5 buffer, 10 mM sodium phosphite, and 100 µM NADPH, 10 µM purified phosphite dehydrogenase and TmCHMO, 1 mM cyclohexanone or the substrate mix. For 10 mM rac-bicyclo-[3.2.0]hept-2-en-6-one, the enzyme concentrations and substrate concentrations were 2 µM and 10 mM, respectively. For the substrate mix, a stock solution with 2 mM of each compound was solubilized in 100% methanol, which was then diluted 1:10 in the final reaction mix. In a closed 20 mL glass vial, 1 mL of that mix was incubated at 30 °C with mild agitation, before analysis. The substrate mixes contained (i) cyclohexanone, rac-bicyclo-[3.2.0]hept-2-en-6-one, thioanisole, 4-octanone, phenylacetone, cyclopentadecanone and stanolone or (ii) (+)-dihydrocarvone, benzaldehyde, isophorone, (-)-menthone, (-)-isomenthone, acetophenone, 1-indanone, and camphor.
Bioconversions with whole cells expressing CHMO
Precultures and the subsequent whole cells bioconversions were carried out in 2 mL deep 96-square well plates (Waters) covered by adhesive seals (AeraSeal film, Excel Scientific) and polypropylene cap mats (Waters), respectively. For all incubations, a Titramax 1000 incubator (Heidolph) at 1,050 rpm was used. Single E. coli colonies harboring the plasmids encoding wild type and mutants CHMO were picked and grown in 300 µL LB medium containing 50 µg/mL ampicillin (15 h, 30 °C). Next, 20 µL of these precultures were mixed with 180 µL LB containing 50 µg/mL ampicillin, 0.02% (w/v) L-arabinose and 11 mM 2-butanone. After 43 h of incubation at 24 °C, analyses were carried out by headspace GC-MS as described below.
Activity assays
NADPH consumption rates were calculated by following the decrease in absorbance at 340 nm (ɛ340 = 6.22 mM -1 cm -1 ) using a spectrophotometer (V-660 Jasco) at 30 °C. Reactions contained enzyme (0.1/10 μM), NADPH (100 μM), and either 10 μM cyclohexanone or 51 μM rac-bicyclo-[3.2.0]hept-2-en-6-one in air-saturated 50 mM Tris/HCl pH 7.5. Under the same conditions, enzyme reactions with NADPH were carried out in the absence of the ketone substrate to determine the uncoupling rate (kun). The standard deviations calculated for all reactions are based on two replicates.
Stopped-flow kinetics
Both the reductive and oxidative half-reactions of the 6xAla TmCHMO variant were studied using the single-mixing mode of a SX20 stopped-flow spectrophotometer equipped with a photodiode array detector (Applied Photophysics, Surrey, UK). In all cases, spectral changes were recorded in duplicate after mixing equal volumes of the reactants prepared in 50 mM Tris/HCl pH 7.5. The flow-circuit of the stopped-flow instrument was made anaerobic by repeated flushing with a dioxygen scrubbing solution containing 5 mM glucose and 0.3 μM glucose oxidase (Aspergillus niger, type VII, Sigma-Aldrich). Nitrogen was bubbled through the NADPH solutions for 10 min to make them anaerobic. With the same purpose, nitrogen was blown on the surface of the enzyme solution for 10 min. Oxidized TmCHMO was reacted with various NADPH concentrations (25-150 µM) under anaerobic conditions at 25 °C. The stopped-flow traces recorded at 440 nm were fit to an exponential function. The resulting observed rates (kobs) were plotted as a function of the NADPH concentrations to calculate the pseudo-first-order rate constant for anaerobic flavin reduction under saturation conditions (kred). Lower concentrations of NADPH could not be assayed under pseudo-first order conditions (≥5-fold excess of NADPH over enzyme) preventing the determination of the apparent macroscopic dissociation constant for binding of the substrate to the enzyme (Kd). To study the oxidative half-reaction, the 6x variant was anaerobically mixed with a stoichiometric amount of NADPH in a gastight vial. Next, the fully reduced TmCHMO was loaded into the stopped-flow instrument and mixed with air-saturated buffer in the stopped-flow cell at either 25 or 4 °C. The stopped-flow traces recorded at 440 nm were fit to exponential functions to determine the kobs. All data were analyzed using the software Pro-Data (Applied Photophysics, Surrey, UK) or GraphPad Prism 6.05 (LA Jolla, CA, USA).
Analytical methods
Determination of melting temperature
For determination of the apparent melting temperature (Tm) of TmCHMO and its mutants, duplicate samples of 25 µL in 50 mM Tris/HCl pH 7.5 buffer were prepared in a 96-well thin wall PCR plate (BioRad). Each sample contained approximately 10 µM purified enzyme. The plate was subjected to a melting curve program, where an RT-PCR machine (CFX96-Touch, Bio-Rad Laboratories) heated from 20 °C to 90 °C, and increased the temperature by 0.5 °C every 10 seconds. At each step, the fluorescence was measured using a 450-490 excitation filter and a 515-530 nm emission filter. The melting point was defined as the temperature when the first derivative of the measured fluorescent curve showed a maximum 15 .
GC-MS analysis
The conversion mixes were extracted 3x with equal amounts of ethyl acetate, and dried over anhydrous 1 µL was injected into the GC in all cases, and the split ratio was 5.0 (for the mixes) or 25 (for cyclohexanone). The software to analyze the chromatograms and MS spectra was GCMSsolution Postrun Analysis 4.11 (Shimadzu), equipped with the NIST11 MS spectra library.
Headspace GC-MS analysis
Whole cell bioconversions of 2-butanone were analyzed by headspace GC-MS using a GCMS-QP2010 (Shimadzu) in an air-conditioned room (21 °C). 250 µL headspace samples were injected onto a HP-1 column (30 m x 0.25 mm x 0.25 µm, Agilent). The injector temperature was set at 150 °C. The column oven temperature during the analyses was 35 °C for 1.7 min. The carrier gas was helium and the split ratio was 40. Standards were used to identify the substrates and products by retention time and their characteristic fragmentation pattern. Calibration curves were carried out for their quantification. Both conversion yield and regioselectivity was calculated based on the amount of the products.
Chiral GC analysis
The conversion mix was extracted three times with equal amounts of tert-butyl methyl ether, dried over anhydrous sodium sulfate, and analyzed via chiral gas chromatography (GC) using a 7890A GC System Figure S3 . GC-chromatogram (top) of conversions of wild-type TmCHMO, and the 3x and 5x mutant with cyclopentadecanone as a substrate. Mass-spectra of the peaks S and P (below, black) identify the peaks as the ketone and lactone, respectively, using the Nist11 library spectra (below, red) as a reference. Figure S4 . Reoxidation of the 6x mutant ( Table 1 in the main text) (a, b) and wild type (c, d) TmCHMO. Spectral changes were recorded after mixing reduced enzyme with air-saturated buffer at 25 °C. Only for wild type TmCHMO, the formation and decay of the C4a-peroxyflavin intermediate (absorbance maximum at 355 nm) was unequivocally observed.
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Supporting Tables   Tables S1. Crystallographic [a] NADPH consumption rates were measured in reactions containing enzyme (0.1/10 μM), NADPH (100 μM), and 10 μM cyclohexanone (cyc) or 51 μM rac-bicyclo-[3.2.0]hept-2-en-6-one (BCH) in air-saturated 50 mM Tris-HCl at pH 7.5 and 30 °C. To determine the uncoupling rate (kun), NADPH and TmCHMO were reacted in the absence of a ketone under the same conditions. The standard deviation is ≤28% and based on two replicates. 
